We ferreted out the best tech deals the internet has to offer this week and rounded them up here. Save on Sonos speakers, Apple iPads, Anker accessories and more.
As seen in the DESTINY-Breast06 trial, a pproximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow.1 These patients may now be ...